Los Angeles Capital Management
BIVV

Los Angeles Capital Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Los Angeles Capital Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-488,370
Closed -$26.3M – 1467
2017
Q4 		$26.3M Buy
488,370
+367,231
+303% +$20.1M 0.14% 178
2017
Q3 		$6.91M Buy
121,139
+72,995
+152% +$4.28M 0.04% 376
2017
Q2 		$2.9M Sell
48,144
-10,165
-17% -$579K 0.02% 532
2017
Q1 		$3.18M Buy
+58,309
New +$2.87M 0.02% 487

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Los Angeles Capital Management's BIVV Position: Q1 2018 in Review

Los Angeles Capital Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 488,370 shares — an estimated $26.3M sold.

Los Angeles Capital Management first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $26.3M in Q4 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Los Angeles Capital Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Los Angeles Capital Management sold 488,370 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $26.3M.
  • Los Angeles Capital Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Los Angeles Capital Management's Bioverativ Inc. Common Stock position peaked at $26.3M in Q4 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Los Angeles Capital Management's 13F filing for Q1 2018, filed 27 Apr 2018.